US 7378251
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
granted A61KA61K38/00
Quick answer
US patent 7378251 (Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein) held by Rigel Pharmaceuticals, Inc. expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/00